Disease management
The company aims to help the self-testing market grow by licensing its core technology for transforming smartphones into IVD devices.
Its web-based platform also guides patients to access appropriate medical care.
The offering includes treatment and screening for prediabetes and Type 2 diabetes.
Coming nearly two years after the company's $100 million Series C, Biofourmis tallied its total raise at $445 million.
However, researchers found that participants' tendencies toward anxiety or pain catastrophizing affected which intervention worked better.
Also, Intuitive India releases its mobile app for surgeons using the da Vinci RAS system.
Also: Virtual ketamine therapy company Nue Life Health brings in $23 million in Series A and debt financing, and Source Health launches out of stealth with a $3 million seed.
Dr. Spencer Dorn, gastroenterologist, professor and vice chair of medicine for care innovation at the University of North Carolina, writes on the potential for innovation to change gastroenterology care.
Also: Pear Therapeutics receives FDA SteP designation for its product candidate focused on acute and chronic pain, and Carbon Health launches its diabetes management program.
The digital platform enables clinicians to adjust their patient's devices remotely and in real-time.